Syngene signs 10-year biologics manufacturing agreement with Zoetis
Syngene's collaboration with Zoetis started in 2011
Syngene's collaboration with Zoetis started in 2011
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
The AICVD tool can predict the risk of cardiovascular disease.
Mittal has previously managed Multiple backed Vikram Hospital as CEO and was associated with Fortis Escorts Heart Institute as zonal director.
Subscribe To Our Newsletter & Stay Updated